225 related articles for article (PubMed ID: 3278422)
1. Low-dose cyclosporine for cadaveric renal transplantation.
Vanderwerf BA; Serota AI
Transplantation; 1988 Feb; 45(2):320-3. PubMed ID: 3278422
[TBL] [Abstract][Full Text] [Related]
2. Effective long-term immunosuppression maintained by low cyclosporine levels in primary cadaveric renal transplant recipients.
Kupin WL; Venkat KK; Norris C; Florence-Green D; Dienst S; Oh HK; Feldkamp C; Levin NW
Transplantation; 1987 Feb; 43(2):214-8. PubMed ID: 3544378
[TBL] [Abstract][Full Text] [Related]
3. Amelioration of chronic renal allograft dysfunction in cyclosporine-treated patients by addition of azathioprine.
Rocher LL; Hodgson RJ; Merion RM; Swartz RD; Keavey S; Turcotte JG; Campbell DA
Transplantation; 1989 Feb; 47(2):249-54. PubMed ID: 2645707
[TBL] [Abstract][Full Text] [Related]
4. Results of the Minnesota randomized prospective trial of cyclosporine versus azathioprine-antilymphocyte globulin for immunosuppression in renal allograft recipients.
Sutherland DE; Fryd DS; Strand MH; Canafax DM; Ascher NL; Payne WD; Simmons RL; Najarian JS
Am J Kidney Dis; 1985 Jun; 5(6):318-27. PubMed ID: 3893106
[TBL] [Abstract][Full Text] [Related]
5. Significance of delayed graft function in cyclosporine-treated recipients of cadaver kidney transplants.
Barry JM; Shively N; Hubert B; Hefty T; Norman DJ; Bennett WM
Transplantation; 1988 Feb; 45(2):346-8. PubMed ID: 3278427
[TBL] [Abstract][Full Text] [Related]
6. Correlation of clinical outcomes after tacrolimus conversion for resistant kidney rejection or cyclosporine toxicity with pathologic staging by the Banff criteria.
Morrissey PE; Gohh R; Shaffer D; Crosson A; Madras PN; Sahyoun AI; Monaco AP
Transplantation; 1997 Mar; 63(6):845-8. PubMed ID: 9089224
[TBL] [Abstract][Full Text] [Related]
7. Complete replacement of methylprednisolone by azathioprine in cyclosporine-treated primary cadaveric renal transplant recipients.
Kupin W; Venkat KK; Oh HK; Dienst S
Transplantation; 1988 Jan; 45(1):53-5. PubMed ID: 3276062
[TBL] [Abstract][Full Text] [Related]
8. HLA-identical renal transplants: impact of cyclosporine on intermediate-term survival and renal function.
Sumrani N; Delaney V; Ding ZK; Butt K; Hong J
Am J Kidney Dis; 1990 Nov; 16(5):417-22. PubMed ID: 2239931
[TBL] [Abstract][Full Text] [Related]
9. Antilymphoblast globulin, cyclosporine, and steroids in cadaveric renal transplantation.
Griño JM; Alsina J; Sabater R; Castelao AM; Gil-Vernet S; Andres E; Sabate I; Mestre M; Seron D; Diaz C
Transplantation; 1990 Jun; 49(6):1114-7. PubMed ID: 2360253
[TBL] [Abstract][Full Text] [Related]
10. Results of conversion from cyclosporine to azathioprine in cadaveric renal transplantation.
Gonwa TA; Nghiem DD; Schulak JA; Corry RJ
Transplantation; 1987 Feb; 43(2):225-8. PubMed ID: 3544380
[TBL] [Abstract][Full Text] [Related]
11. Improved immunosuppression for heart transplant patients using intravenous doses of cyclosporine.
Macris MP; Frazier OH; Van Buren CT; Lammermeier DE; Kahan BD
Transplantation; 1989 Feb; 47(2):311-4. PubMed ID: 2493177
[TBL] [Abstract][Full Text] [Related]
12. Evidence that addition of azathioprine improves renal function in cyclosporine-treated patients with allograft dysfunction.
Pascual J; Marcén R; Orofino L; Quereda C; Mampaso F; Liaño F; Ortuño J
Transplantation; 1991 Aug; 52(2):276-9. PubMed ID: 1871800
[TBL] [Abstract][Full Text] [Related]
13. Cyclosporine plasma levels in renal transplant patients. Association with renal toxicity and allograft rejection.
Klintmalm G; Säwe J; Ringdén O; von Bahr C; Magnusson A
Transplantation; 1985 Feb; 39(2):132-7. PubMed ID: 3881851
[TBL] [Abstract][Full Text] [Related]
14. Cyclosporine toxicity: the effect of combined therapy using cyclosporine, azathioprine, and prednisone.
Lorber MI; Flechner SM; Van Buren CT; Sorensen K; Kerman RH; Kahan BD
Am J Kidney Dis; 1987 Jun; 9(6):476-84. PubMed ID: 3296744
[TBL] [Abstract][Full Text] [Related]
15. The long-term effect of delayed graft function on cadaveric renal transplants treated with low-dose cyclosporine.
Miwa H; Van Loenen M; Vanderwerf BA
Clin Transpl; 1989; ():275-80. PubMed ID: 2487572
[TBL] [Abstract][Full Text] [Related]
16. Detrimental effects of cyclosporin A on long-term graft survival in familial Mediterranean fever renal allograft recipients: experience of two transplantation centers.
Shabtai M; Ben-Haim M; Zemer D; Malinger-Saavedra P; Rosin D; Kuriansky J; Lustig S; Shabtai EL; Shapira Z; Ayalon A
Isr Med Assoc J; 2002 Nov; 4(11 Suppl):935-9. PubMed ID: 12455184
[TBL] [Abstract][Full Text] [Related]
17. Annual trends and triple therapy--1991-2000.
Nishikawa K; Terasaki PI
Clin Transpl; 2001; ():247-69. PubMed ID: 12211788
[TBL] [Abstract][Full Text] [Related]
18. Renal allograft biopsy and conversion of cyclosporine to azathioprine.
Shen SY; Weir MR; Coughlin TR
Transplantation; 1989 Feb; 47(2):223-9. PubMed ID: 2645702
[TBL] [Abstract][Full Text] [Related]
19. A randomized trial comparing triple-drug and double-drug therapy in renal transplantation.
Ponticelli C; Tarantino A; Montagnino G; Aroldi A; Banfi G; De Vecchi A; Zubani R; Berardinelli L; Vegeto A
Transplantation; 1988 May; 45(5):913-8. PubMed ID: 3285536
[TBL] [Abstract][Full Text] [Related]
20. [Effectiveness and safety of conversion therapy with the combination of sirolimus with low dose cyclosporine in renal transplantation recipients: a five-year clinical observation].
Zhu L; Ding T; Wang XX; Lin ZB; Chen G
Zhonghua Yi Xue Za Zhi; 2016 May; 96(20):1556-61. PubMed ID: 27266681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
